Lobeglitazone Sulfate

洛贝格列酮硫酸盐

Report date: 2025/11/18 14:57:34
NME

Base Information

Drug NameLobeglitazone Sulfate
Drug Alias NameLobeglitazonumLobeglitazonaDuvieIDR-105CKD-501 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsLiver DysfunctionDiabetes Mellitus, Type 2Renal Insufficiency +[4] 
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2013/07/04
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesAclipse Therapeutics LLCChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Gastroparesis
Inactive IndicationsLiver DysfunctionRenal Insufficiency

Other Information

ATC CodeA10B
Related LinksWikipediaDrugBank